nature.com search

Loading Filters

Showing 1–47 of 47 results

Loading Filters

Research | 12 May 2020
The ORNATE India Project: United Kingdom–India Research Collaboration to tackle visual impairment due to diabetic retinopathy
- S. Sivaprasad
- , R. Raman
- , D. Conroy
- , Mohan V
- , R. Wittenberg
- , R. Rajalakshmi
- , A. Majeed
- , S. Krishnakumar
- , T. Prevost
- , S. Parameswaran
- , P. Turowski
- , U. Maheswari
- , R. Khobragade
- , G. Netuveli
- , R. Sadanandan
- , J. Greenwood
- , K. Ramasamy
- , M. Rao
- , C. Bergeles
- , T. Das
- , Pramod Bhende
- , Padmaja K. Rani
- , Rupak Roy
- , Supita Das
- , V. Narendran
- , George Manayath
- , Giridhar Anantharaman
- , Mahesh Gopalakrishnan
- , Sundaram Natarajan
- , Radhika Krishnan
- , Sheena Liz Mani
- , Manisha Agarwal
- , Tapas Padhi
- , Umesh Behera
- , Harsha Bhattacharjee
- , Manabjyoti Barman
- , Gajendra Chawla
- , Alok Sen
- , Moneesh Saxena
- , Asim K. Sil
- , Subhratanu Chakabarty
- , Thomas Cherian
- , Reesha KR
- , Rushikesh Naigaonkar
- , Abishek Desai
- , Col Madan Deshpande
- & Sucheta Kulkarni
Eye 34 , 1279–1286

Rights & permissionsfor article The ORNATE India Project: United Kingdom–India Research Collaboration to tackle visual impairment due to diabetic retinopathy . Opens in a new window.
Editorial | 11 January 2018
Welcome message from the new Editor-in-Chief
- S Sivaprasad
Eye 32 , 49–49

Rights & permissionsfor article Welcome message from the new Editor-in-Chief . Opens in a new window.
23 June 2017 | Open
Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration
- J S Talks
- , P James
- , S Sivaprasad
- , R L Johnston
- , M McKibbin
- , A J Lotery
- , F Ghanchi
- , N Patel
- , C Bailey
- , S Mahmood
- , A Lobo
- , B Paul
- , Q Kashif
- , C Santiago
- , G Walters
- , M Tahir
- , B Mushtaq
- , k Ahmed
- , M McKibbin
- , S Sivaprasad
- & J Talks
Eye 31 , 1613–1620

Rights & permissionsfor article Appropriateness of quality standards for meaningful intercentre comparisons of aflibercept service provision for neovascular age-related macular degeneration . Opens in a new window.
Amendments and Corrections | 14 April 2016
Erratum: The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary
- S Sivaprasad
- , W M Amoaku
- , P Hykin
- & R V O Guideline Group
Eye 30 , 642–642

Rights & permissionsfor article Erratum: The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary . Opens in a new window.
Amendments and Corrections | 10 December 2015
Erratum: The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary
- S Sivaprasad
- , W M Amoaku
- & P Hykin
Eye 29 , 1640–1640

Rights & permissionsfor article Erratum: The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary . Opens in a new window.
Amendments and Corrections | 13 June 2013
Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
- A Tufail
- , P J Patel
- , S Sivaprasad
- , W Amoaku
- , A C Browning
- , M Cole
- , R Gale
- , S George
- , A J Lotery
- , M Majid
- , M McKibbin
- , G Menon
- , Y Yang
- , C Andrews
- , C Brittain
- & A Osborne
Eye 27 , 786–786

Rights & permissionsfor article Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study . Opens in a new window.
Amendments and Corrections | 12 June 2014
Erratum: Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1)
- R Mathew
- , E Pearce
- , R Muniraju
- , A Abdel-Hay
- & S Sivaprasad
Eye 28 , 778–778

Rights & permissionsfor article Erratum: Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1) . Opens in a new window.
Amendments and Corrections | 13 March 2014
Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
- A Tufail
- , P J Patel
- , S Sivaprasad
- , W Amoaku
- , A C Browning
- , M Cole
- , R Gale
- , S George
- , A J Lotery
- , M Majid
- , M McKibbin
- , G Menon
- , Y Yang
- , C Andrews
- , C Brittain
- & A Osborne
Eye 28 , 365–365

Rights & permissionsfor article Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study . Opens in a new window.
Research | 4 June 2018
Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes
- Irini Chatziralli
- , Shane O. Regan
- , Ryian Mohamed
- , James Talks
- , Sobha Sivaprasad
- , A. J. Lotery
- , F. Ghanchi
- , N. Patel
- , C. Bailey
- , S. Mahmood
- , A. Lobo
- , B. Paul
- , Q. Kashif
- , C. Santiago
- , G. Walters
- , M. Tahir
- , B. Mushtaq
- , Κ. Ahmed
- , M. McKibbin
- , S. Sivaprasad
- & J. Talks
Eye 32 , 1523–1529

Rights & permissionsfor article Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes . Opens in a new window.
28 April 2017
Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema
- L Nicholson
- , N V Patrao
- , J Ramu
- , C Vazquez-Alfageme
- , M Muwas
- , R Rajendram
- , P G Hykin
- & S Sivaprasad
Eye 31 , 1358–1364

Rights & permissionsfor article Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema . Opens in a new window.
16 June 2017
Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data
- I Chatziralli
- , M Santarelli
- , N Patrao
- , L Nicholson
- , M Zola
- , R Rajendram
- , P Hykin
- & S Sivaprasad
Eye 31 , 1594–1599

Rights & permissionsfor article Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data . Opens in a new window.
20 May 2016 | Open
Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
- F G Holz
- , R Tadayoni
- , S Beatty
- , A R Berger
- , M G Cereda
- , P Hykin
- , G Staurenghi
- , K Wittrup-Jensen
- , J Nilsson
- , K Kim
- & S Sivaprasad
Eye 30 , 1063–1071

Rights & permissionsfor article Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study . Opens in a new window.
11 December 2015
Spare the rods and spoil the retina: revisited
- S Sivaprasad
- & G Arden
Eye 30 , 189–192

Rights & permissionsfor article Spare the rods and spoil the retina: revisited . Opens in a new window.
Amendments and Corrections | 12 January 2017
Erratum: Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
- F G Holz
- , R Tadayoni
- , S Beatty
- , A R Berger
- , M G Cereda
- , P Hykin
- , G Staurenghi
- , K Wittrup-Jensen
- , J Nilsson
- , K Kim
- & S Sivaprasad
Eye 31 , 166–166

Rights & permissionsfor article Erratum: Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study . Opens in a new window.
Reviews | 28 August 2015
The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary
- S Sivaprasad
- , W M Amoaku
- , P Hykin
- , Sobha Sivaprasad
- , Winfried Amoaku
- , Tom Williamson
- , Paul Dodson
- , James Talks
- , Katherine Talks
- , Khanchan Bhan
- & Philip Hykin
Eye 29 , 1633–1638

Rights & permissionsfor article The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary . Opens in a new window.
9 July 2015 | Open
Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
- M McKibbin
- , H Devonport
- , R Gale
- , M Gavin
- , A Lotery
- , S Mahmood
- , P J Patel
- , A Ross
- , S Sivaprasad
- , J Talks
- & G Walters
Eye 29 , S1–S11

Rights & permissionsfor article Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel . Opens in a new window.
23 October 2015
A randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study)
- J Ramu
- , Y Yang
- , G Menon
- , C Bailey
- , N Narendran
- , C Bunce
- , A Quartilho
- , A T Prevost
- , P Hykin
- & S Sivaprasad
Eye 29 , 1603–1612

Rights & permissionsfor article A randomized clinical trial comparing fixed <i>vs</i> pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study) . Opens in a new window.
3 January 2014
Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1)
- R Mathew
- , E Pearce
- , R Muniraju
- , A Abdul-Hey
- & S Sivaprasad
Eye 28 , 318–326

Rights & permissionsfor article Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1) . Opens in a new window.
6 March 2015
Myopic foveoschisis: a clinical review
- R Gohil
- , S Sivaprasad
- , L T Han
- , R Mathew
- , G Kiousis
- & Y Yang
Eye 29 , 593–601

Rights & permissionsfor article Myopic foveoschisis: a clinical review . Opens in a new window.
Amendments and Corrections | 8 October 2015
Erratum: Defining response to anti-VEGF therapies in neovascular AMD
- W M Amoaku
- , U Chakravarthy
- , R Gale
- , M Gavin
- , F Ghanchi
- , J Gibson
- , S Harding
- , R L Johnston
- , S P Kelly
- , A Lotery
- , S Mahmood
- , G Menon
- , S Sivaprasad
- , J Talks
- , A Tufail
- & Y Yang
Eye 29 , 1397–1398

Rights & permissionsfor article Erratum: Defining response to anti-VEGF therapies in neovascular AMD . Opens in a new window.
Correspondence | 20 November 2015
Reply: ‘Myopic foveoschisis: an ectatic retinopathy, not a schisis’
- R Gohil
- , S Sivaprasad
- , L T Han
- , R Mathew
- , G Kiousis
- & Y Yang
Eye 30 , 329–330

Rights & permissionsfor article Reply: ‘Myopic foveoschisis: an ectatic retinopathy, not a schisis’ . Opens in a new window.
7 June 2013
Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial)
- G Menon
- , M Chandran
- , S Sivaprasad
- , R Chavan
- , N Narendran
- & Y Yang
Eye 27 , 959–963

Rights & permissionsfor article Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial) . Opens in a new window.
6 January 2012
Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: The DRIVE UK Study
- B Gupta
- , S Sivaprasad
- , R Wong
- , A Laidlaw
- , T L Jackson
- , D McHugh
- & T H Williamson
Eye 26 , 510–516

Rights & permissionsfor article Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: The DRIVE UK Study . Opens in a new window.
16 February 2007
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration
- K Y Chau
- , S Sivaprasad
- , N Patel
- , T A Donaldson
- , P J Luthert
- & N V Chong
Eye 22 , 855–859

Rights & permissionsfor article Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration . Opens in a new window.
14 August 2009
Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature
- S Jyothi
- , H Chowdhury
- , M Elagouz
- & S Sivaprasad
Eye 24 , 816–824

Rights & permissionsfor article Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature . Opens in a new window.
16 September 2011
Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab
- S Sivaprasad
- , E Pearce
- & V Chong
Eye 25 , 1612–1616

Rights & permissionsfor article Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab . Opens in a new window.
21 October 2011
Regression of early diabetic macular oedema is associated with prevention of dark adaptation
- G B Arden
- , S Jyothi
- , C H Hogg
- , Y F Lee
- & S Sivaprasad
Eye 25 , 1546–1554

Rights & permissionsfor article Regression of early diabetic macular oedema is associated with prevention of dark adaptation . Opens in a new window.
6 November 2009
Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy
- S Jyothi
- , H R Chowdhury
- , V Chong
- & S Sivaprasad
Eye 24 , 1018–1023

Rights & permissionsfor article Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy . Opens in a new window.
24 February 2006
Blood pressure control in type II diabetics with diabetic retinopathy
- S Sivaprasad
- & H Jackson
Eye 21 , 708–711

Rights & permissionsfor article Blood pressure control in type II diabetics with diabetic retinopathy . Opens in a new window.
Correspondence | 1 October 2004
Photodynamic therapy for age-related macular degeneration
- S Sivaprasad
- , C J Hammond
- & H Jackson
Eye 19 , 1027–1028

Rights & permissionsfor article Photodynamic therapy for age-related macular degeneration . Opens in a new window.
3 February 2006
Pulsatile ocular blood flow in asymmetric age-related macular degeneration
- R Sandhu
- , S Sivaprasad
- , S P Shah
- , T Adewoyin
- & N V Chong
Eye 21 , 506–511

Rights & permissionsfor article Pulsatile ocular blood flow in asymmetric age-related macular degeneration . Opens in a new window.
13 May 2011
Five-year visual outcome following laser photocoagulation of diabetic macular oedema
- S Jyothi
- & S Sivaprasad
Eye 25 , 850–859

Rights & permissionsfor article Five-year visual outcome following laser photocoagulation of diabetic macular oedema . Opens in a new window.
15 April 2011
Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation
- R Vemala
- , S Koshy
- & S Sivaprasad
Eye 25 , 901–908

Rights & permissionsfor article Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation . Opens in a new window.
16 February 2007
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration
- K Y Chau
- , S Sivaprasad
- , N Patel
- , T A Donaldson
- , P J Luthert
- & N V Chong
Eye 21 , 1511–1515

Rights & permissionsfor article Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration . Opens in a new window.
16 December 2011
Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration
- R Mathew
- & S Sivaprasad
Eye 26 , 389–393

Rights & permissionsfor article Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration . Opens in a new window.
Correspondence | 17 March 2006
Homonymous hemianopia and exotropia: an important management issue
- G M Saleh
- , S Sivaprasad
- & C J Hammond
Eye 20 , 1402–1404

Rights & permissionsfor article Homonymous hemianopia and exotropia: an important management issue . Opens in a new window.
19 November 2010
Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab
- E Pearce
- , S Sivaprasad
- & N V Chong
Eye 25 , 149–153

Rights & permissionsfor article Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab . Opens in a new window.
1 March 2013
Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
- A Tufail
- , P J Patel
- , S Sivaprasad
- , W Amoaku
- , A C Browning
- , M Cole
- , R Gale
- , S George
- , A J Lotery
- , M Majid
- , M McKibbin
- , G Menon
- , Y Yang
- , C Andrews
- , C Brittain
- & A Osborne
Eye 27 , 709–715

Rights & permissionsfor article Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study . Opens in a new window.
25 September 2009
Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience
- S Sivaprasad
- , P Hykin
- , A Saeed
- , S Beatty
- , S Grisanti
- , G Staurenghi
- , J L Olea
- , A Campos
- , A Barbosa
- , L Rito
- , R Silva
- , R Faria
- , B Eldem
- , S Kadayıfçılar
- , P Kolar
- , N Feucht
- & L Maestroni
Eye 24 , 793–798

Rights & permissionsfor article Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration: Pan-European experience . Opens in a new window.
15 April 2005
Does lesion size determine the success rate of photodynamic therapy for age-related macular degeneration?
- S Sivaprasad
- , G M Saleh
- & H Jackson
Eye 20 , 43–45

Rights & permissionsfor article Does lesion size determine the success rate of photodynamic therapy for age-related macular degeneration? . Opens in a new window.
26 August 2005
Second eye of patients with unilateral neovascular age-related macular degeneration: Caucasians vs Chinese
- S Sivaprasad
- , W L Membrey
- , V Sivagnanavel
- , J G Gonzalez
- , D T L Liu
- , W M Chan
- , D S C Lam
- , H Jackson
- & N V Chong
Eye 20 , 923–926

Rights & permissionsfor article Second eye of patients with unilateral neovascular age-related macular degeneration: Caucasians <i>vs</i> Chinese . Opens in a new window.
7 August 2009
Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than age-related macular degeneration
- B Gupta
- , M Elagouz
- & S Sivaprasad
Eye 24 , 203–213

Rights & permissionsfor article Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than age-related macular degeneration . Opens in a new window.
11 January 2013
Optimisation of an automated drusen-quantifying software for the analysis of drusen distribution in patients with age-related macular degeneration
- B B Ong
- , N Lee
- , W P Lee
- , E Pearce
- , S Sivaprasad
- , C C Klaver
- , R T Smith
- & N V Chong
Eye 27 , 554–560

Rights & permissionsfor article Optimisation of an automated drusen-quantifying software for the analysis of drusen distribution in patients with age-related macular degeneration . Opens in a new window.
13 January 2012
Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice
- B Gupta
- , R Wong
- , S Sivaprasad
- & T H Williamson
Eye 26 , 576–582

Rights & permissionsfor article Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice . Opens in a new window.
13 January 2006
The complement system and age-related macular degeneration
- S Sivaprasad
- & N V Chong
Eye 20 , 867–872

Rights & permissionsfor article The complement system and age-related macular degeneration . Opens in a new window.
17 April 2015
Defining response to anti-VEGF therapies in neovascular AMD
- W M Amoaku
- , U Chakravarthy
- , R Gale
- , M Gavin
- , F Ghanchi
- , J Gibson
- , S Harding
- , R L Johnston
- , S Kelly
- , A Lotery
- , S Mahmood
- , G Menon
- , S Sivaprasad
- , J Talks
- , A Tufail
- & Y Yang
Eye 29 , 721–731

Rights & permissionsfor article Defining response to anti-VEGF therapies in neovascular AMD . Opens in a new window.
20 June 2014
Photodynamic therapy for central serous chorioretinopathy
- O C Erikitola
- , R Crosby-Nwaobi
- , A J Lotery
- & S Sivaprasad
Eye 28 , 944–957

Rights & permissionsfor article Photodynamic therapy for central serous chorioretinopathy . Opens in a new window.

Quick links